InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Thibaut du Fayet, Chief Executive Officer. Insider active across 1 companies, notably Phaxiam Therapeutics. Aggregated, 1 reports have been logged. The latest transaction was filed on 23 June 2023 — Souscription. Regulator: AMF. All data is openly available.
Declarations1 total
€33,46654,862 shares@ €0.61100.0% of flow
ActionHors plateforme de négociation
2023DD917744·
1 of 1 declaration
About Thibaut du Fayet
Thibaut du Fayet is the Chief Executive Officer of Phaxiam Therapeutics, a company specializing in the development of innovative treatments. He is responsible for the strategic and operational direction of the company, aiming to improve patient health through advanced therapeutic solutions. His leadership is essential for the growth and success of Phaxiam.
